June 9, 2025
The Effect of Trump’s Tariffs on the European Pharmaceutical and Biopharmaceutical Industry
The European pharmaceutical and biopharmaceutical industries face significant challenges as the U.S. considers imposing tariffs on imports.
These proposed tariffs, including a potential 25% levy, threaten to disrupt global supply chains, inflate costs, and compress profit margins. With Europe exporting billions in medicines annually to the U.S., European stakeholders must act decisively to adapt to this evolving trade landscape, ensuring resilience and maintaining competitiveness in global markets.
DOWNLOAD HERE
Download the full paper in which A&M experts explore how businesses can navigate these challenges through operational optimisation and strategic planning.